The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 330:1717-1722 June 16, 1994 Number 24
NextNext

Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients
Michelle A. Hayes, Andrew C. Timmins, Ernest Yau, Mark Palazzo, Charles J. Hinds, and David Watson

 Sign up for free e-toc
 

This Article
-Full Text

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Elevation of systemic oxygen delivery and consumption has been associated with an improved outcome in critically ill patients. We conducted a randomized trial to determine whether boosting oxygen delivery by infusing the inotropic agent dobutamine would improve the outcome in a diverse group of such patients.

Methods On the basis of previously published recommendations, we established the following goals: a cardiac index above 4.5 liters per minute per square meter of body-surface area, oxygen delivery above 600 ml per minute per square meter, and oxygen consumption above 170 ml per minute per square meter. If these goals were not achieved with volume expansion alone, patients were randomly assigned to a treatment or control group. The treatment group received intravenous dobutamine (5 to 200 µg per kilogram of body weight per minute) until all three goals had been achieved. Dobutamine was administered to the control group only if the cardiac index was below 2.8 liters per minute per square meter.

Results A total of 109 patients were studied. In nine patients the therapeutic goals were achieved with volume expansion alone; all nine patients survived to leave the hospital. Fifty patients were randomly assigned to the treatment group, and 50 to the control group. During treatment, there were no differences between the two groups in mean arterial pressure or oxygen consumption, despite a significantly higher cardiac index and level of oxygen delivery in the treatment group (P<0.05). Although the predicted risk of death during hospitalization was 34 percent for both groups, the in-hospital mortality was lower in the control group (34 percent) than in the treatment group (54 percent) (P = 0.04; 95 percent confidence interval, 0.9 to 39.1 percent).

Conclusions The use of dobutamine to boost the cardiac index and systemic oxygen delivery failed to improve the outcome in this heterogeneous group of critically ill patients. Contrary to what might have been expected, our results suggest that in some cases aggressive efforts to increase oxygen consumption may have been detrimental. .


Source Information

From the Departments of Anesthesia and Intensive Care, St. Bartholomew's Hospitals at Smithfield and Homerton (M.A.H., A.C.T., E.H.S.Y., C.J.H., D.W.), and the Departments of Anesthesia and Intensive Care, Charing Cross Hospital (M.P.) -- all in London.

Address reprint requests to Dr. Watson at the Department of Anesthesia, St. Bartholomew's Hospital at Smithfield, West Smithfield, London EC1A 7BE, United Kingdom.

Full Text of this Article


Related Letters:

Elevation of Systemic Oxygen Delivery in the Treatment of Critically Ill Patients
Vincent J.-L., Bihari D. J., Bohrer H., Schmidt H., Bach A., Shoemaker W. C., Appel P. L., Hayes M. A., Palazzo M., Hinds C. J., Watson D.
Extract | Full Text  
N Engl J Med 1994; 331:1160-1162, Oct 27, 1994. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.